Orazi, A <br/><br/>
Effects of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow.  [electronic resource] 

 -  Experimental hematology  Sep 1996 
 - 1289-97 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0301-472X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Breast Neoplasms--drug therapy<br/>Cell Count--drug effects<br/>Female<br/>Hematopoiesis--drug effects<br/>Humans<br/>Interleukin-11--administration & dosage<br/>Megakaryocytes--pathology<br/>Ploidies<br/>Recombinant Proteins--administration & dosage